Previous studies found that FGFR3 gene mutations were associated with many epithelial malignancies, including cervical carcinoma, nasopharyngeal carcinoma, colorectal cancer and bladder cancer [23-26]. This evidence concerns the gene FGFR3 and nasopharyngeal carcinoma.